Buchumschlag

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin

Aim: To investigate the relationship of sodium/iodide symporter (NIS) expression with molecular phenotype of highly and low malignant cell lines of human breast cancer (BC) with different sensitivity to doxorubicin (Dox). Materials and Methods: The cell lines used in the analysis included T47D, MCF-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental Oncology
Datum:	2016
Hauptverfasser:	Lukianova, N.Yu., Andriiv, A.V., Chekhun, V.F.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2016
Schlagworte:	Original contributions
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/137741
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin / N.Yu. Lukianova, A.V. Andriiv, V.F. Chekhun // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 169-171. — Бібліогр.: 18 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
von: Yu. Lukianova, et al.
Veröffentlicht: (2017)

Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
von: Medviediev, O., et al.
Veröffentlicht: (2016)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
von: Todor, I.N., et al.
Veröffentlicht: (2012)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
von: Rusetskaya, N.V., et al.
Veröffentlicht: (2011)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: S. V. Chekhun, et al.
Veröffentlicht: (2014)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: Chekhun, S.V., et al.
Veröffentlicht: (2014)

Features of hepcidin expression in patients with breast cancer
von: Yu. Lukianova, et al.
Veröffentlicht: (2015)

Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
von: V. F. Chekhun, et al.
Veröffentlicht: (2016)

Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
von: Chorna, I.V., et al.
Veröffentlicht: (2014)

Effect of anticancer drugs on breast cancer cells sensitive and resistant to doxorubicin: expression of mRNAs of TGF-β and its receptors
von: I. V. Chorna, et al.
Veröffentlicht: (2014)

Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
von: Yu, Z., et al.
Veröffentlicht: (2007)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: Chekhun, S., et al.
Veröffentlicht: (2013)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: S. Chekhun, et al.
Veröffentlicht: (2013)

Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
von: Naleskina, L.A., et al.
Veröffentlicht: (2016)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
von: Chekhun, V.F., et al.
Veröffentlicht: (2018)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
von: S. M. Hrybach, et al.
Veröffentlicht: (2018)

Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
von: Chekhun, V.F., et al.
Veröffentlicht: (2023)

Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
von: N. P. Yurchenko, et al.
Veröffentlicht: (2020)

EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
von: L. M. Kovalevska, et al.
Veröffentlicht: (2019)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: O. V. Shepil, et al.
Veröffentlicht: (2014)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: Shepil, O.V., et al.
Veröffentlicht: (2014)

The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
von: V. F. Chekhun, et al.
Veröffentlicht: (2017)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
von: Bereznaya, N.M., et al.
Veröffentlicht: (2008)

Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
von: L. A. Nalieskina, et al.
Veröffentlicht: (2017)

Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
von: Todor, I.N., et al.
Veröffentlicht: (2015)

Heterogeneity of premetastatic niches gene expression in breast cancer cells
von: L. A. Tashireva, et al.
Veröffentlicht: (2015)

Adaptor protein Ruk/CIN85 modulates resistance to doxorubicin of murine 4T1 breast cancer cells
von: I. R. Horak, et al.
Veröffentlicht: (2018)

Expression analisis of the ITSN2 and TKS5 mRNA isoforms in human malignant breast tumors
von: S. V. Kropyvko, et al.
Veröffentlicht: (2018)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

Human microbiota and effectiveness of cancer chemotherapy
von: Shvets, Yu.V., et al.
Veröffentlicht: (2023)

Visualization of iron nanoparticles accumulation and distribution features in sensitive and resistant to antitumor drugs human breast cancer cells after different time intervals of cultivation with liposomal ferromagnetic
von: L. A. Nalieskina, et al.
Veröffentlicht: (2011)

Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
von: Kropyvko, S.V., et al.
Veröffentlicht: (2019)

Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
von: O. V. Ponomareva
Veröffentlicht: (2018)

Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival
von: Goncharuk, I.V., et al.
Veröffentlicht: (2009)

Epigenetics in breast cancer
von: Atalay, C.
Veröffentlicht: (2013)

Epigenetics in breast cancer
von: C. Atalay
Veröffentlicht: (2013)